Rizwan Romee

18PUBLICATIONS
137CO-AUTHORS
Molecular targetsEpidemiological modellingCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Sep 29, 2026
Spatially confined IL-12 programs CAR-NK through mTORC1 to coordinate antitumor immune networks.

|Apr 21, 2026
eGFR Discordance and Its Association with Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation and Adoptive T-Cell Therapies.

|Apr 17, 2026
CAR-NK Cells in B-cell Lymphoma: A New Frontier toward Accessible and Scalable Cellular Therapy.

|Dec 08, 2025
Surface expression of antitoxin on engineered bacteria neutralizes genotoxic colibactin in the gut.

Shaobo Yang, Zongqi Wang, Chengyuan Fang

|Oct 08, 2025
Selective HLA knockdown and PD-L1 expression prevent allogeneic CAR-NK cell rejection and enhance safety and anti-tumor responses in xenograft mice.

Fuguo Liu, Mubin Tarannum, Yingjie Zhao

|Apr 14, 2025
Engineering innate immune cells for cancer immunotherapy.

Mubin Tarannum, Xizhong Ding, Marta Barisa

Pageof 3

Frequent Collaborators

5 joint publications

Jerome Ritz

5 joint publications

Shaobo Yang

4 joint publications

Jianzhu Chen

3 joint publications

Robert J Soiffer